Search by Drug Name or NDC
NDC 25021-0408-51 eptifibatide 0.75 mg/mL Details
eptifibatide 0.75 mg/mL
eptifibatide is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is EPTIFIBATIDE.
Product Information
| NDC | 25021-0408 |
|---|---|
| Product ID | 25021-408_9a1ccb0d-f56a-467a-9c2f-ad4e4dadf0f1 |
| Associated GPIs | 85153030002010 |
| GCN Sequence Number | 039891 |
| GCN Sequence Number Description | eptifibatide VIAL 75MG/100ML INTRAVEN |
| HIC3 | M9P |
| HIC3 Description | PLATELET AGGREGATION INHIBITORS |
| GCN | 49151 |
| HICL Sequence Number | 018422 |
| HICL Sequence Number Description | EPTIFIBATIDE |
| Brand/Generic | Generic |
| Proprietary Name | eptifibatide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | eptifibatide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 0.75 |
| Active Ingredient Units | mg/mL |
| Substance Name | EPTIFIBATIDE |
| Labeler Name | Sagent Pharmaceuticals |
| Pharmaceutical Class | Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA204693 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 25021-0408-51 (25021040851)
| NDC Package Code | 25021-408-51 |
|---|---|
| Billing NDC | 25021040851 |
| Package | 1 VIAL in 1 CARTON (25021-408-51) / 100 mL in 1 VIAL |
| Marketing Start Date | 2018-07-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |